Dear Readers,
We just wrapped up our Green Drives Conference and Expo at the Danada House in Wheaton, and I am more optimistic than ever about the future of clean transportation in Illinois.
This year’s event brought together nearly 175 participants, a dozen exhibitors, and more than two dozen alternative-fuel vehicles and technologies, creating a full day of learning and connection for fleets across the region.
From the Governor’s video remarks to sessions on fuels, fleet strategies, and funding opportunities, Green Drives was designed to give fleet managers practical tools for choosing the right fuels for the right jobs. Speakers shared real-world results with electric vehicles, renewable and biobased fuels, propane, and CNG/RNG, as well as insights on workforce development and charging infrastructure. We also highlighted a Featured Fleet that is successfully using a multifuel approach to reduce emissions while keeping operations reliable.
If you would like a deeper dive into this year’s program, we have posted a Green Drives 2026 Recap on our website, along with presentation materials and a recording of the event.
Together, these conversations underscored something important: there is no single path to cleaner transportation. Illinois fleets need options, support, and trusted information to make the choices that fit their missions, budgets, and communities. That is exactly the space where IACT is working—to connect you with practical solutions, partners, and examples you can learn from.
Next month, you’ll meet some of the people behind the scenes who make our events meaningful and help keep IACT moving toward its vision for Illinois.
All my best,
Ann Schneider
Chair, Illinois Alliance for Clean Transportation

Dr. Ann Schneider became IACT’s chair in 2026, bringing 36 years of professional experience in public finance, public policy, and solutions development and 18 years of executive-level transportation policy experience to the role. Now a transportation policy consultant, Dr. Schneider has helped clients secure nearly $357 million in grant funding.


